MOPH group

Lei Miao (Ph.D. 2016)

  • Thesis Title: The role of tumor desmoplasia is nanoparticle delivery of drugs and genes
  • Employer: Postdoctoral Research Associate at Massachusetts Institute of Technology (MIT)

Tojan Rahhal (Ph.D. 2016)

  • Thesis Title: Engineering PRINT particles for Pulmonary Delivery of Therapeutics
  • Employer: Consultant at Alliance Professional Development

Dylan Glatt (Ph.D. 2016)

  • Thesis title: Monoclonal antibody-mediated tumor targeting and drug delivery to solid tumors
  • Employer: Research Scientist at Gilead Sciences

James Huckle (Ph.D. 2014)

  • Thesis Title: C2E2 An Orally Administered Rodionuclide Decorporation Agent
  • Employer: Scientist – Basic Pharmaceutics

Zhijian He (Ph.D. 2014)

  • Thesis Title: Poly (2-oxazoline)s as new drug delivery systems
  • Employer: Research Scientist, Clinical Pharmacology and Pharmacokinetics at INC Research

Tammy Shen (Ph.D. 2014)

  • Thesis Title: Development and Characterization of PRINT Particles as Drug Delivery Vehicles in the Lung
  • Employer: Senior Scientist at Merck

Luke Roode (Ph.D. 2014)

  • Thesis Title: Sub-Tumor Distribution of Print Nanoparticles and Its Application for Nucleic Acid Delivery
  • Employer: Medical Writer I at QuintileIMS

Ping Ma (Ph.D. 2012)

  • Thesis Title and Major Adviser: Drug-loaded nanoparticles for improved cancer treatment: engineering, in-vitro, and in-vivo evaluation (Dr. Mumper)
  • Employer: Hospira Inc.

Lan Feng (Ph.D. 2012)

  • Thesis Title and Major Adviser: Oil-filled Lipid Nanoparticles Containing Docetaxel Conjugates for Controlled Drug Release (Dr. Mumper)
  • Employer: Novartis

Elizabeth Vasievich (Ph.D. 2011)

  • Thesis Title and Major Adviser: LIPID-BASED CANCER VACCINES (Dr. Huang)
  • Employer: Genentech

Bo He (Ph.D. 2011)

  • Thesis Title and Major Adviser: Delivery of MG53 for muscle membrane repair attenuates congestive heart failure and muscular dystrophy (Dr. Xiao)
  • Employer: IRTA Fellow at NIEHS

Saurabh Wadhwa (Ph.D. 2011)

  • Thesis Title and Major Adviser: Intracellular delivery of reactive oxygen species generating polypeptide-drug conjugates for cancer therapy (Dr. Mumper)
  • Employer: Regeneron Pharmaceuticals, NY

Michael Hackett (Ph.D. 2011)

  • Thesis Title and Major Adviser: Paclitaxel-2`O-pentadecylhemiglutarate: A Chemical Strategy for Albumin Based drug Delivery (Dr. Cho)
  • Employer: Postdoc research associate at UNC Eshelman School of Pharmacy

Matthew Dufek (Ph.D. 2011)

  • Thesis Title and Major Adviser: The Effect of the Dynamic Interplay of P-Glycoprotein and Cytochrome P450 3A on Intestinal Absorption (Dr. Thakker)
  • Employer: Scientist in the Department of Clinical Pharmacology at Genentech in San Francisco, CA.